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100.000 to 33.750.000 HCV RNA coppies/mL. HCV genotype
were found: G1 in 19, G2 in 2, G3 in 9, G4 in 2 and mixed G
in 5 patients. Sustained viral response (SVR) was achived in
21/27 (77,77%), relapse (R) was found in 4 (14,81%) patients
and 2 patients (7,40%) were nonresponders (NR). Therapy
was deﬁnitly interrupted in only one patient. We had to stop
treatment temporaly and to reduse dose of antiviral drugs
in 10 (27%) patients. Adverse effects of therapy were found
in 30 (81,1%) patients
Conclusions: Treatment of CHC in IDUs was successful and
it shows that more IDUs should be treated with antiviral
therapy.
doi:10.1016/j.ijid.2008.05.1094
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Background: It is known that the nosocomial viral hepati-
tis agents Hepatitis B (HBV), Hepatitis D (HDV), and Hepatitis
C (HCV) viruses are transmitted by the close contact and
invasive procedures. The nosocomial viral hepatitis (NVH)
transmission cases were followed for last seven years period.
Materials and Methods: Between 1999 to 2006; 28 NVH
cases were followed for 12—72 months at the Research and
Application Hospital that is committed to the University. It
was taken the notice of the negative chronic viral hepatitis
markers and normal value of transaminases of the cases. The
cases that were considered of transmission of HBV, HCV, and
HDV at the outside of the hospital were excluded from the
study. All the cases were evaluated for the acute viral hep-
atitis markers for HBV, HCV and HDV, after 15th and 90th day
of the suspected transmission. The cases who were known
that transmission of HBV, HDV and HCV was occurred were
re-evaluated for the medical status of before transmission
and present.
Findings and Results: There were totally 28 cases (eigh-
teen were man, ten were women) ages between 20 to 67
were suspected of the transmission of nosocomial viral hep-
atitis. Six of them were doctors, six of them were nurses,
four of them were medical stuff and twenty were patients
that were hospitalized for another medical reason. It was
determined that all the hospital stuff had their viral hep-
atitis agent transmission because of needle-sticks and ten
of the patients had their transmission because of endo-
scopic and invasive procedures. From these 28 cases: 5
cases (four medical staff, and one patient) exposured HBV,
previously known 4 chronic hepatitis B patients exposured
nosocomial HDV transmission and 19 cases (6 doctors, 6
nurses, 7 patients) exposured nosocomial HCV transmission.
At the end of the observation; from the 4 medical stuff and
one patient who didn’t get any prophylaxis two of them
got Anti-HBs seroconversion, but the other two stuffs got
their diseases chronically HBV carriers. Four patients who
were previously known that were chronic viral hepatitis B,
acquired their HDV exposure and transmission because of the
endoscopic procedures and superinfection were occurred at
all four of them. These four HDV superinfection patients
were given interferon treatment (10 million IU/3 times a
week) for one year. After the treatment their transami-
nases decreased to the normal values and HDV-RNA of all
four patients were negative. The two of four nosocomially
HDV exposured patients had Anti-HBs seroconversion and all
four patients had negative Anti-HDV tests. After one year,
the two patients who had Anti-HBs seroconversation and got
HBsAg positivity again. HCV exposured 12 items (6 doctors,
6 nurses) got nor transaminase elevation neither Anti-HCV
or HCV-RNA positivity. From the HCV exposured 7 patients;
the two of them got spontaneous clearance, ﬁve of them got
acute HCV infection and treated for one year. But one male
patient with acute HCV infection who didn’t tolerate the
treatment got a decomposed liver disease after two years.
At one acute HCV infected female and spontaneously cleared
patient got a ﬂare of HCV infection during an immunosuppre-
sive treatment because of her temporal arteritis. The other
four patients who had received pegilated interferon treat-
ment for one year got sustained response to the treatment.
Conclusions: As a result from ﬁve nosocomial HBV infec-
tions two had a chronic hepatitis B infection. From 19
nosocomial HCV infection there was one chronical infec-
tion. From four nosocomial HDV infection were treated
successfully. The viral hepatitis agents causes chronic ill-
ness at immun compromised patients. These patients must
be evaluated for prophylaxis after a HBV exposure. Although
HCV is still an important viral pathogen for nosocomial
transmission; it makes chronic viral hepatitis that has long
progression time period at healthy people.
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Background: Although several blood borne viral infec-
tions are transmitted sexually, yet acquiring hepatitis C virus
(HCV) infection by this route is debated. Risk of chronicity
with HCV infection is high and increases co-morbidity when
present along with HIV in high risk groups.
Methods: We recruited 426 female sex workers (FSWs)
who consented by Respondent Driven Sampling (RDS) tech-
nique in a Linked Anonymous strategy. The respondents
provided behavioral data and biological samples. Serum
samples were tested for HIV and HCV by ELISA. To assess
the associated risk factors, samples were also tested for
HSV-2 and syphilis. Urine samples were tested for gonorrhea
and chlamydial infections by Aptima Gen probe. Data were
analyzed using SPSS 10.0 statistical software.
Results: Of the 426 FSWs enrolled, the overall anti-HCV
antibody positivity was 9.6%; 45.9% among those who were
IDUs and in 7.5% with no history of injecting drug abuse,
blood transfusion or tattooing. HIV-1 antibody was positive
in 13.6% while 2.3% had detectable HBsAg. HIV-HCV co-
infection was present in 36.2%. Among the STIs, HCV was
signiﬁcantly associated with HSV-2 in 15.5% (OR 2.9, 95%
